digital therapeutic

By Laura Lovett 03:26 pm July 13, 2020
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.  The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...

Credit: EIT Digital

By Tammy Lovell 04:29 am June 29, 2020
Nordic digital therapeutics company SidekickHealth is partnering with pharma giant Pfizer to launch a digital therapeutics platform, in a deal thought to be worth more than $8 million. The solution combines scientific expertise and digital technologies, giving patients a tool to help them maintain healthy lifestyles and improve their disease management and quality of life, while providing...
By Laura Lovett 03:32 pm May 6, 2020
Digital mental health company Limbix scored $9 million in Series A funding. The new round was led by GSR Ventures with participation from sequoia Capital, Storm Ventures, NexGen Venture Partners and BIXINK Therapeutics.  This comes roughly four months after the Palo Alto-based startup was selected as one of 27 digital health companies in MassChallenge HealthTech’s 2020 accelerator class. WHAT IT...
By Laura Lovett 03:48 pm December 12, 2019
A video game-like digital therapy may be key to helping reduce cognitive impairments in adults living with major depressive disorder (MDD).  Results out of a new study conducted by Akili interactive found that patients using the company’s AKL-T03 significantly improved their sustained attention compared to their peers in the control group.  In the study, which was presented at the Meeting of the...
By Dave Muoio and Laura Lovett 03:45 pm September 27, 2019
It’s been two years since the first software-only digital therapeutic got the FDA greenlight, but the industry is still very much in its infancy and continuing to evolve. New entrances are emerging from the world of health, pharma, tech and finance. As the industry matures, it's grappling with existential questions including regulation, reimbursement models and, as always, the definition of a...
By Laura Lovett 04:22 pm September 25, 2019
There’s no denying that digital therapeutics look and feel different than traditional medications. Instead of popping open a medication bottle, users are logging into an app to access treatment. But the differences don’t stop at the look. While the risk of toxicity is an ever-looming question in the pharma space, the same isn’t true for digital solutions.  Stakeholders at the digital therapeutics...
By Dave Muoio 03:30 pm August 6, 2019
Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week. The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...

Omada CEO Sean Duffy. Photo credit: Omada

By Laura Lovett 03:57 pm July 11, 2019
Omada Health, the digital health company that recently raised $73 million, came on to the digital health scene in 2011 with a focus on diabetes and chronic conditions. As the company continues to carve out its legacy in the digital health world, it is taking a cue from a more established industry. “We’re one of the most life sciences-like digital health companies. We don’t fit perfectly into any...
By Dave Muoio 03:48 pm May 21, 2019
Minneapolis-based NightWare — maker of a smartwatch therapeutic for people with nightmare disorder and PTSD-driven nightmares — has received breakthrough therapy designation for its in-development product. In addition, the company is launching two new placebo-controlled randomized clinical trials for its digital intervention, one of which is being conducted within Department of Veterans Affairs...
By Dave Muoio 11:32 am May 8, 2019
A randomized controlled trial recently published in npj Digital Medicine found Kaia Health’s app-based exercise therapy for lower back pain (LBP) to be an effective treatment for multidisciplinary patients, and could be more effective than a standard strategy of individual physiotherapy sessions paired with online education. TOPLINE DATA In the investigation — which was sponsored by Kaia Health...